Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 20c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q1 EPS of ($0.87), $0.20 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $890 thousand versus the consensus estimate of $8.12 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Nomura/Instinet Downgrades RHB Bank (RHBBANK:MK) to Neutral
• AiRWA receives Nasdaq deficiency notice over late 10-K filing
• Goldman Sachs Downgrades Guangzhou Automobile Group (2238:HK) (GNZUF) to Sell